Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-10

Clinical Trial Update: Midfacial Product Selection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for a midfacial product addressing facial volume loss has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Erevna Innovations Inc. | Conditions: Facial Volume Loss | Phase 4 | Status: COMPLETED